TriLink

The financing will support growth in Maravai's three life science segments: bioprocess impurity testing, oligonucleotide synthesis, and protein detection.

NEW YORK (GenomeWeb) — New England Biolabs will supply RNA synthesis reagents to TriLink Biotechnologies under an agreement announced by the companies today.

Researchers at the University of North Texas Health Science Center recently developed an assay capable of quantifying nuclear DNA, mitochondrial DNA copy number, and the ratio of age-related deletions in the mitochondrial genome, in a single qPCR.

NEW YORK (GenomeWeb News) – Trilink BioTechnologies said today that it has inked a new licensing agreement with Biofortuna allowing the UK firm to use Trilink's hot start deoxynucleotides for freeze-drying molecular diagnostic kit development and production service.

TriLink Biotechnologies this week launched MitoPrimers for mitochondrial DNA PCR amplification and sequencing in forensic identification.

TriLink Biotechnologies said today that it has inked a licensing agreement with Denmark's QuantiBact to offer twisted intercalating nucleic acid, or TINA, modified oligonucleotides.

NEW YORK (GenomeWeb News) – TriLink BioTechnologies announced today a licensing deal with QuantiBact to offer twisted intercalating nucleic acid, or TINA, modified oligos.

NEW YORK (GenomeWeb News) – TriLink BioTechnologies today announced a $130,000 award from the National Institutes of Health to develop a sample preparation method for next-generation sequencing.

The Mayo Foundation for Medical Education and Research has been awarded US Patent No. 8,362,227, "Detection of Clostridium difficile."
Franklin Cockerill, Thomas Smith, Jon Rosenblatt, and Lynne Sloan are named as inventors.

NEW YORK (GenomeWeb News) – TriLink BioTechnologies said today that it has inked a licensing deal with Li-Cor Biosciences covering labeling of nucleic acids with near-infrared dyes.

Pages

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.